Proactive Investors - Run By Investors For Investors

Pressure BioSciences has an eye toward uplisting as it strengthens balance sheet

Pressure BioSciences (OTCMKTS:PBIO, OTCQB: PBIO) CEO Ric Schumacher tells Proactive Investors the life sciences company has strengthened its balance sheet with the conversion of an additional $7.24mln of debt into equity, bringing the total amount of debt that has converted into equity over the past four weeks to more than $13.6mln.

Schumacher says the company is on track to uplist to a national exchange, and would like to make the move by the end of the year.

Meet Carnarvon Petroleum Ltd, Bass Oil Ltd, High Peak Royalties Ltd, Global Energy Ventures Ltd and Po Valley Energy Ltd at our event, Melbourne , 12 March 2019. Register here »
View full PBIO profile View Profile

Pressure BioSciences Inc. Timeline

© Proactive Investors 2019

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use